{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T13:26:58Z","timestamp":1696166818646},"reference-count":34,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.vaccine.2012.08.072","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T13:30:15Z","timestamp":1347024615000},"page":"6632-6635","source":"Crossref","is-referenced-by-count":3,"title":["Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel"],"prefix":"10.1016","volume":"30","author":[{"given":"Yael","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehud","family":"Kaliner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itamar","family":"Grotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda L.","family":"Danon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.08.072_bib0005","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2006.09.037","article-title":"Smallpox vaccines: past, present and future","volume":"118","author":"Parrino","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0010","first-page":"71","article-title":"The elimination of smallpox from Israel","volume":"3","author":"Slater","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0015","series-title":"Biohazard: the chilling true story of the largest covert biological weapons program in the world\u2014told from inside by the man who ran it","author":"Alibek","year":"1999"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Handerson","year":"1999","journal-title":"Science"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2012.08.072_bib0025","first-page":"1","article-title":"Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Recommendation for using smallpox vaccine in a pre-event vaccination program","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-2143(03)00143-4","article-title":"Smallpox vaccines: current and future","volume":"142","author":"Bonilla-Guerrero","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0035","first-page":"507","article-title":"Preparation for an outbreak of smallpox in Israel","volume":"4","author":"Slater","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0040","unstructured":"Israel Ministry of Health. http:\/\/www.health.gov.il\/hozer\/mk20.2002.pdf [accessed May 2012]."},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2012.08.072_bib0045","first-page":"S868","article-title":"The incidence of primary immunodeficiency syndromes in Israel","volume":"4","author":"Golan","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0050","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"Kemper","year":"2002","journal-title":"Eff Clin Pract"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1067\/mai.2002.128052","article-title":"Smallpox vaccination: risk considerations for patients with atopic dermatitis","volume":"110","author":"Engler","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2012.08.072_bib0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijid.2008.08.007","article-title":"Smallpox revaccination of 21000 first responders in Israel: lessons learned","volume":"13","author":"Annis","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0065","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/423851","article-title":"Clinical and immune responses after revaccination of Israeli adults with the Lister strain of vaccinia virus","volume":"190","author":"Orr","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/milmed\/165.4.287","article-title":"Adverse reactions to smallpox vaccine: the Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys","volume":"165","author":"Haim","year":"2000","journal-title":"Mil Med"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.08.072_bib0075","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/524749","article-title":"Monitoring of the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board","volume":"46","author":"Neff","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0080","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January\u2013October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0085","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0090","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0095","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0100","series-title":"Attenuated smallpox vaccine LC16m8 protects cynomoglus monkeys from lethal SIV monkeypox-zaire challenge","author":"Empig","year":"2006"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0105","series-title":"Safety and efficacy study of attenuated smallpox vaccine LC16m8 in animals","author":"Funatsu","year":"2006"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0110","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0115","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m6, an attenuated smallpox vaccinia in vaccinia-na\u00efve adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1203\/00006450-197508000-00002","article-title":"Evaluation of two kinds of smallpox vaccine: CVI-78 and calf lymph vaccine. I. Clinical and serological response to primary vaccination","volume":"9","author":"Wesley","year":"1975","journal-title":"Pediatr Res"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2012.08.072_bib0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J Gen Virol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2012.08.072_bib0130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0135","first-page":"225","article-title":"Vaccination against pox diseases under immunosuppressive conditions","volume":"41","author":"Mayr","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0145","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0150","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE","volume":"28","author":"von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2008.07.025","article-title":"Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination","volume":"122","author":"Sano","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0160","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1089\/aid.2006.0226","article-title":"Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART","volume":"23","author":"Cosma","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2012.08.072_bib0165","first-page":"S215","article-title":"New smallpox vaccine protects people with atopic dermatitis","author":"Hurley","year":"2011","journal-title":"American Academy of Psychiatry"},{"key":"10.1016\/j.vaccine.2012.08.072_bib0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy","volume":"10","author":"Wittek","year":"2006","journal-title":"Int J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201290X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201290X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T11:54:46Z","timestamp":1562154886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201290X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":34,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0264410X1201290X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}